Yixin Yangshen Granules Target HIF−1 Signaling to Modulate the Neuroimmune Microenvironment in Alzheimer’s Disease: Insights from Integrative Multi-Omics and Deep Learning
Open Access
- 18 March 2026
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 502
Abstract
Background/Objectives: Alzheimer’s disease (AD) involves amyloid and tau pathology with neuroimmune dysregulation, and Yixin Yangshen Granules (YXYS) shows neuroprotective promise, though mechanisms remain unclear. This study aimed to elucidate the multi-target mechanisms of YXYS in AD. Methods: The study began by analyzing a public human AD hippocampal snRNA-seq dataset to identify cell-type-specific pathological pathways and profiled YXYS constituents by UPLC-QTOF-MS. In vitro, YXYS cytoprotection against mitochondrial dysfunction and oxidative stress was tested in Aβ25–35-challenged HT22 cells; in vivo efficacy was assessed in Aβ1–42-induced mice via behavioral and histopathological analyses. Integrated transcriptomic and proteomic profiling of brain tissue, with ELISA, qRT-PCR, and Western blot validation, confirmed pathway targets. Using the intersection of transcriptomic and proteomic targets as biological input, the DTIAM deep learning framework was employed to prioritize active YXYS constituents. Finally, molecular docking and 100-ns dynamics simulations demonstrated direct binding of Ganosporelactone A to HIF−1α. Results: AD snRNA-seq analysis highlighted HIF−1 and AGE-RAGE signaling as prominent pathways in the AD hippocampus, particularly enriched in brain microvascular endothelial cells, implicating neurovascular hypoxic and inflammatory stress. In Aβ-induced mice, YXYS improved cognition, reduced Aβ pathology, suppressed neuroinflammation, and promoted neuronal survival, consistent with in vitro evidence of restored mitochondrial function. Multi-omics confirmed convergence on HIF−1 and AGE-RAGE pathways, with YXYS rebalancing the neuroimmune microenvironment by reducing pro-inflammatory M0 macrophages. Screening against these consensus signaling hubs, deep learning analysis prioritized Ganosporelactone A as the top-ranked modulator, and molecular further demonstrated the stable binding of Ganosporelactone A to HIF−1α, linking YXYS to mitigation of hypoxic stress. Conclusions: Guided by multi-omics and deep learning, our findings suggest that YXYS may alleviate AD-related phenotypes through multi-target modulation of the HIF−1 and AGE-RAGE pathways, with associated improvements in neuro-immune homeostasis and reductions in oxidative stress, neuroinflammation, and hypoxia.Keywords
Funding Information
- STI2030-Major Projects (2022ZD0211600)
- National Natural Science Foundation of China (82174210)
- Scientific Research Facility Special Foundation for Operation and Maintenance (102160222020040009016)
- Scientific Research Facility Special Foundation for Operation and Maintenance (160202001000210007)
- Fundamental Research Funds for the Central Public Welfare Research Institutes (ZZ14-FL-005)
- Fundamental Research Funds for the Central Public Welfare Research Institutes (ZZ13-YQ-073)
This publication has 41 references indexed in Scilit:
- Oxidative stress–mediated neuroinflammation in Alzheimer’s diseaseNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- Therapeutic potential of the medicinal mushroom Ganoderma lucidum against Alzheimer's diseaseBiomedicine & Pharmacotherapy, 2024
- Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic miceExperimental Neurology, 2023
- Signal pathways in the treatment of Alzheimer’s disease with traditional Chinese medicineBiomedicine & Pharmacotherapy, 2022
- Yixin Ningshen Tablet Alleviates Comorbidity of Myocardial Infarction and Depression by Enhancing Myocardial Energy Metabolism and Increasing Availability of Monoamine NeurotransmitterChinese Journal of Integrative Medicine, 2022
- Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damageAnnals of Medicine & Surgery, 2022
- Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbsBiomedicine & Pharmacotherapy, 2022
- Alzheimer's disease: Recent treatment strategiesEuropean Journal of Pharmacology, 2020
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Contribution of hypoxia to Alzheimer’s disease: is HIF-1α a mediator of neurodegeneration?Cellular and Molecular Life Sciences, 2009